MICRO LABORATORIES INC
10QSB, 2000-08-28
PHARMACEUTICAL PREPARATIONS
Previous: NORTH SHORE CAPITAL I INC, 10QSB/A, 2000-08-28
Next: MICRO LABORATORIES INC, 10QSB, EX-27, 2000-08-28



















































<PAGE>2
                           UNITED STATES
                SECURITIES AND EXCHANGE COMMISSION

                       Washington, D.C. 20549

                          FORM 10-QSB

[X]   QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d)
      OF THE SECURITIES AND EXCHANGE ACT OF 1934
      For the Quarter ended June 30, 2000

[ ]   TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE
      EXCHANGE ACT
      For the transition period               to
                                    ----------    ----------

          Commission file number -  000-28787

                    Micro Laboratories, Inc.
         Exact name of Registrant as specified in its charter)

      NEVADA                                          05-049-4587
 (State or other   (Primary Standard Industrial    (I.R.S. Employer
jurisdictions      Classification Code Number)  Identification number)
of incorporation
or organization


29 Lakeside Drive, Johnston, Rhode Island                  02919
 (Address of principal executive offices)                (Zip Code)

                       Telephone:  (401) 949-3562
            (Registrant's telephone number, including area code)

Indicate by check mark whether the Registrant (1) has filed all reports
required to be filed by Section 13 or 15(d) of the Securities and Exchange
Act of 1934 during the preceding twelve months (or such shorter period that
the Registrant was required to file such reports), and (2) has been subject
to file such filing requirements for the past thirty days.

Yes    x      No
    ------       ------

Indicate the number of shares outstanding of each of the issuer's classes of
common stock, as of the close of the period covered by this report:

                11,338,000 Shares of Common Stock ($.001 par value)
                               (Title of Class)


Transitional Small Business Disclosure Format (check one):
    Yes           No    x
       -------       -------











<PAGE>3

                        Micro Laboratories, Inc.


PART I:        Financial Information

                     ITEM 1 - Financial statements

                     ITEM 2 - Management's' discussion and analysis of
                     financial condition and results of operations

PART II:      Other Information

                     ITEM 6 - Exhibits and Reports on Form 8-K








<PAGE>4

PART I

Item 1. Financial Statements:

                      MICRO LABORATORIES, INC.
                   (A Development Stage Company)
                           Balance Sheet
                      June 30, 2000 and 1999

ASSETS
                                   2000                   1999
                                  ------                 ------

Current Assets
   Cash                         $     0                 $65,628
   Investory                     27,040                   4,375
   Prepaid expenses               20,033                 21,539
   Loans and exchanges            27,665                  3,215
                                --------              ---------
   Total Current Assets           74,737                 94,757

Property and Equipment
   Machinery and equipment         47,070                44,524
   Computer software               11,723               140,755
  Furniture and fixtures            3,664                 3,664
  Leasehold improvements            2,357                 2,357
                                 --------              --------
Less accumulated depreciation     (17,791)               14,070)
                                 --------              --------
    Net Property and Equipment     47,023               177,230

Other Assets
  Deposits                            600                   600
  Formulas and trademarks
   (net of accum. Amort.)          60,600                75,921
                                 --------              --------
   Total Other Assets              61,200                76,521

Total Assets                     $182,960              $348,508
                                 ========              ========

 LIABILITIES AND EQUITY

Current Liabilities
   Accounts payable-trade         $261,562              $12,667
  Due to related parties           141,296               45,000
                                 ---------           ----------
   Total Current Liabilities       402,858               57,667

Stockholders' Equity
        Common Stock                11,338                5,553
         Additional paid-in
             -capital            1,531,345            1,170,600
    Accumulated deficit         (1,762,581)            (885,312)
         Total Stockholders
            Equity                (219,898)             290,841
                                 ---------            ---------
Total Liabilities and Equity      $182,960             $348,508
                                ==========             ========



<PAGE>5

                MICRO LABORATORIES INC.
            (A Development Stage Company)
                  Statement of Income
       For the Tree Months Ended June 30, 2000 and 1999

                                     2000                 1999

Revenue
Sales                            $       0             $     172

Operating Expenses
   Purchases                             0                 4,941
   Freight                               0                     0
  Advertising                            0                26,886
  Depreciation expense               1,559                     0
  Insurance expense                  1,264                     0
Amortization expense                     0                     0
Auto                                   528                 1,434
Bank service charge                      0                   870
Bookkeeping service                  2,000                 3,301
Consulting                               0                52,767
Education and training                   0                     0
Legal and accounting                10,000                13,791
Fullfilment expenses                     0                50,000
Office expense                           0                     0
Dues and subscription                    0                   925
Postage                                  0                   295
Printing                               686                     0
Professional fees                        0                 4,365
Rent                                     0                15,300
Meal and entertainment                   0                   630
Repairs and maintenance                  0                 1,759
Research and development expense         0                88,897
Office supplies                          0                 3,077
Service expense                          0                   250
Telephone                            1,663                 7,934
Travel                                   0                   100
Utilities                              125                   936
Miscellaneous                            0                     0
Payroll and payroll taxes                0                     0
Licenses                               200                     0
                                 ---------            ----------
   Total Operating Expenses         18,025               278,458
                                ----------            ----------

Loss from Operations               (18,025)              278,458
                                 ---------            ----------

Other Income
   Gain on sale of assets                0                    0
Interest income                          0                    0
                                 ---------           ----------
   Total Other Income                    0                    0
                                 ---------           ----------
Loss before Income Taxes           (18,025)            (276,605)

Provision for Income Taxes
       Provision for state
         income taxes                    0                    0
                                  --------            ---------
            Total Provision for
              Income Taxes               0                    0

Net Loss                          $(18,025)           $(276,605)
                                   =======             ========

Net Loss per common share          ($.001)



<PAGE>6

                 MICRO LABORATORIES, INC.
                 (A Development State Company)
                  Statement of Cash Flows
            For the Three Months Ended June 30, 2000
<TABLE>
<CAPTION>
                                                  2000           1999
<S>                                               <C>            <C>
Cash flows from operating activities:
   Net loss                                     $(18,025)     $(276,605)
   Adjustments to reconcile net income to
      Net cash used for operating activities:
        Depreciation and amortization              1,559              0
     (Increase) decrease in assets
     Deposits                                          0          4,000
    Prepaid expenses                                   0          3,939
     Inventory                                         0          7,779
Loans/exchanges                                        0         23,860
   Increase (decrease in liabilities:
   Accounts payable                                    0        (33,079)
   Notes payable                                  16,466        (64,030)
                                               ---------     ----------
      Net cash used by operating activities       18,025        (57,531)

Investing activities:
   Acquisition of intangible assets                    0        (10,271)
    Gain on sale of asset                              0          8,653
   Acquisition of property and equipment (net)         0        (11,517)
                                                --------       --------
          Net cash used for investing
              activities                               0        (13,135)

Net increase (decrease) in cash during the period      0       (347,271)

Cash balance, beginning of period                      0        412,899

Cash balance, end of period                   $        0         $65,628
                                               =========       =========
</TABLE>



<PAGE>7

Note 1.    In the opinion of management of Micro Laboratories, Inc.,
the unaudited financial statements of Micro Laboratories, Inc. for the
interim period shown, include all adjustments, necessary for a fair
presentation of the financial position at June 30, 2000, and the
results of operations and cash flows for the period then ended.  The
results of operations for the interim periods shown may not be
indicative of the results that may be expected for the fiscal year.
These statements should be read in conjunction with the financial
statements and notes thereto included in the Company's Form 10-K for
the year March 31, 2000.





<PAGE>8
              Micro Laboratories, Inc.

PART I (cont.)

Item 2. Management's Discussion and Analysis of Financial
Condition and Results of Operations:

Trends and Uncertainties. Demand for Micro's products will be
dependent on, among other things, general economic conditions, which
are cyclical in nature.  Inasmuch as a major portion of the
Corporation's activities is the receipt of revenues from the sale of
its products, Micro's business operations may be adversely affected by
its competitors and prolonged recessionary periods.

Micro is entering a phase of conversion from a Development Stage
Corporation to an Operational Corporation.  Agreements have been
reached to provide key personnel in the areas of marketing and sales.
An agreement has been reached with three large distributors to include
the west coast, mid west and New England.  Preliminary market research
was conducted to arrive at the flavorings for the Micro SprayT product
line.  Micro sent a representative to the National Association of
Chain Drug Stores (NACDS) trade convention in Philadelphia, PA also
the packaging show in Chicago Ill. The Corporation plans to use a
"target" marketing approach for the distribution of its Micro SprayT
product line.

Capital and Source of Liquidity. Micro currently has no material
commitments for capital expenditures.

For the three months ended June 30, 2000, Micro did not pursue any
investing activities.

For the three months ended June 30, 1999, Micro acquired property and
equipment (net) of $11,517, a gain on the sale of asset of $7,653 and
acquired intangible assets of $10,271.   For the three months ended
June 30, 1999, Micro had net cash used for investing activities of
$(13,135).

For the three months ended June 30, 2000 and 1999, Micro did not
pursue any financing activities.

On a long term basis, liquidity is dependent on commencement of
operations as discussed above, receipt of revenues, additional
infusions of capital and debt financing.  Micro believes that
additional capital and debt financing in the short term will allow
Micro to increase its marketing and sales efforts and become a fully
operational Corporation thereafter resulting in increased revenue and
greater liquidity in the long term.  However, there can be no
assurance that Micro will be able to obtain additional equity or debt
financing in the future, if at all.

Results of Operations.
Micro is accurately classified as a "development stage Corporation"
and as such has conducted startup and development operations that
include:
   completed photo shoots, created Corporation logos, brochures, sales
literature, product labels and packaging design, UPCs
   prepared the product line of six items for distribution roll out
   completed negotiations with three large distributors to include
west coast, mid west, and New England to represent and sell the
companies product lines to national chains

Micro has not received any material revenues since inception.

For the three months ended June 30, 2000, Micro had a net loss of
$18,025.   Operating expenses for the three months ended June 2000
were $18,025 and consisted of insurance of $1,559, amortization
expense of $1,264, bank service charge of $528, bookkeeping service of
$2,000, fullfilment expenses of $10,000, professional fees of $686,
telephone of $1,663, utilities of 125 and licenses of $200.

For the three months ended June 30, 1999, Micro had a net loss of
$278,458 which consisted of purchases of $4,941, advertising of
$26,886, auto of $1,434, bank service charge of $870, bookkeeping
service of 3,301, consulting of $52,767, legal and accounting of
$13,791, fullfilment expenses of $50,000, dues and subscription of
$925, postage of $295, professional fees of $4,365, rent of $15,300,



<PAGE>9

meal and entertainment of $630, repairs and maintenance of $1,759,
research and development of $88,897, office supplies of $3,077,
service expense of $250, telephone of $7,934, travel of $100 and
utilities of $936.

Plan of Operation. Micro is in the development stage and has not
conducted any significant operations to date or received any material
operating revenues.  Micro may experience problems; delays, expenses
and difficulties sometimes encountered by an enterprise in Micro's
stage of development, many of which are beyond Micro's control.  These
include, but are not limited to, unanticipated problems relating to
additional costs and expenses that may exceed current estimates and
competition.

Micro is not delinquent in any of its obligations even though Micro
has generated limited operating revenues.  The Corporation intends to
market its products and services utilizing cash made available from
the private sale of its securities and operations. Micro's management
is of the opinion that the proceeds of the sales of its securities and
future revenues will be sufficient to pay its expenses for the next
twelve months.



<PAGE>10

MICRO LABORATORIES, INC.

PART II


Item 6. Exhibits and Reports on Form 8-K

(a)   Exhibits (numbered in accordance with Item 601 of
      Regulation S-K)

      None

(b)   Reports on Form 8-K

None




                           SIGNATURE

Pursuant to the requirements of the Securities Exchange Act
of 1934, the registrant has duly caused this report to be
signed on its behalf by the undersigned thereunto duly
authorized.


                                      /s/ Robert Thistle
                                 ----------------------------
                                     Robert Thistle, President


August 28, 2000












© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission